THE OVARIAN CANCER INSTITUTE INC
EIN: 58-2445245Atlanta, GAZIP: 30327
G30 - Diseases, Disorders & Medical Disciplines501(c)(3)
Mission
THE OVARIAN CANCER INSTITUTE EXISTS TO (1) DEVELOP INNOVATIVE RESEARCH LEADING TO EARLIER DETECTION AND MORE EFFECTIVE CONTROL OF OVARIAN CANCER (2) TO EDUCATE AND HEIGHTEN WOMEN'S AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND TREATMENT (3) TO INVESTIGATE NEWER MODALITIES OF TREATMENT.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1M | $0 | $843k |
| 2023 | $899k | $0 | $602k |
Compensation
2024
2023
Similar Organizations
$805k revenue
Same sector (G30)Similar revenue ($805k vs $1M)Same state (Georgia)Comparable compensation levels
Cancer Support Services Inc
$529k revenueAugusta, GA
Same sector (G30)Comparable revenue ($529k vs $1M)Same state (Georgia)Similar median compensation ($93k vs $97k)
FLM FOUNDATION INC
$831k revenueAtlanta, GA
Same sector (G30)Similar revenue ($831k vs $1M)Same state (Georgia)
SPECTRUM AUTISM SUPPORT GROUP INC
$1.1M revenueSuwanee, GA
Similar sector (G)Very similar revenue ($1.1M vs $1M)Same state (Georgia)Comparable compensation levels
READSOURCE INC
$1.1M revenueAtlanta, GA
Similar sector (G)Very similar revenue ($1.1M vs $1M)Same state (Georgia)
AFLAC CHILDHOOD CANCER FOUNDATION INC
$1.4M revenueColumbus, GA
Same sector (G30)Comparable revenue ($1.4M vs $1M)Same state (Georgia)
NATIONAL TUBERCULOSIS COALITION OF
$872k revenueAlpharetta, GA
Similar sector (G)Similar revenue ($872k vs $1M)Same state (Georgia)Similar median compensation ($99k vs $97k)
IAN'S FRIENDS FOUNDATION INC
$1.1M revenueAtlanta, GA
Similar sector (G)Very similar revenue ($1.1M vs $1M)Same state (Georgia)
SAVANNAH ASSOCIATION FOR THE BLIND
$814k revenueSavannah, GA
Similar sector (G)Similar revenue ($814k vs $1M)Same state (Georgia)Similar median compensation ($105k vs $97k)
MUCOLIPIDOSIS TYPE IV FOUNDATION INC
$1.1M revenueAtlanta, GA
Similar sector (G)Very similar revenue ($1.1M vs $1M)Same state (Georgia)
Data from IRS Form 990 filings (2023-2024).